Home > Products > Product Information
Techpool Roan® Ulinastatin for Injection
Ulinastatin for Injection
acute pancreatitis,chronic recurrent pancreatitis and acute circulatory failure
In 1999, it was launched into market and made China to be the second country which could produce this medicine.
In 2001, it was recognized  as one of “key new products of China”.
In 2004, it was recognized as a national exemplary high-tech industry project.

In 2006, it was reported by the People’s Government of Guangdong as one of award-winning companies to win the 9th China Patent Award.

In 2007, it won the first prize of Guangdong Science and Technology Award

In 2008,the invention patent "the application of Ulinastatin and its pharmaceutical composition for the treatment of severe acute respiratory syndrome" was granted by the United States Patent and Trademark Office.

At present,Techpool is the sole legal manufacture of Ulinastatin(API) and Ulinastatin for injection in China.

Product ReviewPrescribing Information

Abundant clinical application studies have confirmed that Techpool Roan® is a specific medicine for the treatment of acute pancreatitis,it can also reduce the risk of shock effectively. Protect organ function and reduce postoperative complications while administered in perioperative period. 


Many domestic and foreign  researches prove that Ulinastatin is able to stabilize membrane structures such as lysosome, and inhibit the excessive release of inflammatory cytokines.Therefore it exhibits excellent anti-inflammatory effects during treatment of some critical diseases,such as sepsis, severe burns, DIC (Disseminated Intravascular Coagulation) ,ARDS (Acute Respiratory Distress Syndrome), SIRS and MODS,and significantly improves survival rate and effective rate. 


Techpool Roan® adopts the gold standard of viral inactivation which isrecognised by both WHO and FDA – a method which inactivates viruses by heating the solution at 60℃ for 10 hours.


The research on Ulinastatin by the Medicine and Health Development Centre of the Ministry of Health’s indicates that Techpool Roan® has outstanding performance in the treatment of acute pancreatitis and perioperative organ protection.


Ulinastatin is a type of refined glycoprotein extracted from human urine, it is a proteinase inhibitor and be able to inhibit the activity of trypsin and various pancreatic enzymes, and is widely applied in the treatment of pancreatitis. In addition, Ulinastatin can stabilise the membrane of lysosome, inhibit the release of lysosome enzyme and the formation of myocardial depressant factor. Thus it can be used in the rescue and treatment of acute circulatory failure.

Ulinastatin for Injection


[Drug Name]

Generic name:  Ulinastatin for Injection

Product Name: Techpool Roan®

Pinyin: Zhusheyong Wusitading


[Indications]

1.Acute pancreatitis  2.Chronic recurrent pancreatitis 3.Assistant medicine for rescue of acute circulatory failure 


[Strength]

(A) 50,000 U/vial  (2) 100 000 U/vial


[Pharmacological]

Ulinastatin is one kind of glycoprotein extracted and refined from human urine, it is one kind of  proteinase inhibitors. Ulinastatin can inhibit the activity of trypsin and various pancreatic enzymes, widely used in clinical treatment of Pancreatitis. Moreover, Ulinastatin can stablize the membrance of lysosome and inhibit the release of lysosomal enzyme and the formation of myocardial depressant factor. So Ulinastatin can be used in the rescue and treatment  of acute circulatory failure.